Product Code: 978-1-68038-867-1
Parenteral Nutrition Market Growth & Trends:
The global parenteral nutrition market size is expected to reach USD 10.68 billion by 2030, registering a CAGR of 6.01% from 2024 to 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of malnutrition, rising metabolic disorders, growing geriatric population, and advancement in healthcare infrastructure are some of the factors driving the market growth. The rising geriatric population has significantly contributed to the increasing demand for parenteral nutrition (PN) as the elderly population is more vulnerable to several diseases. For instance, according to the Population Reference Bureau (PRB), the population of the U.S. aged above 65 years is expected to increase from 58 million in 2022 to 82 million in 2050.
The presence of a large pool of geriatric population with low immunity levels and susceptibility to neurological diseases, cardiovascular disorders, cancer, and spinal injuries is a high-impact rendering driver of the market. Moreover, a surge in essential nutrition deficiency among critically ill patients; and growing awareness about hospital-related malnutrition are a few key factors increasing PN adoption. Parenteral drug administration provides the benefit of fast action and lower dose delivery, which prevent various adverse effects because of dietary imbalances, thereby promoting market growth. However, the high risk of infection during administration and the growing preference for enteral nutrition among patients are major factors restricting the market growth. The growing population worldwide has increased healthcare costs and household food expenditures.
Hence, a higher birth rate is expected to impact nutrition levels, thereby driving market growth. According to the United Nations statistics, the world population is expected to increase from 8 billion in 2022 to 9.7 billion in 2050 and 10.4 billion by the mid-2080s. This rising population can increase the scarcity of nutritional ingredients, fueling market growth. Realized natality plays a more prominent role than absolute natality (crude birth rate), as it includes environmental as well as resource pressures, such as water, food, and medication requirements per birth. Realized natality has been growing in the last decade and the trend is anticipated to continue over the forecast period. In 2020, the natality rate reported by the National Center for Health Statistics (NCHS) was 11.99 births per 1,000 population. Furthermore, the percentage of lower-weight infants was 8.0%, thereby boosting the demand for PN products worldwide.
key Request a free sample copy or view report summary: Parenteral Nutrition Market Report
Parenteral Nutrition Market Report Highlights:
Based on nutrient type, the market is segmented into carbohydrates, parenteral lipid emulsions, single-dose amino acid solution, trace elements, and vitamins & minerals. The single-dose amino acid segment held the largest revenue share of 30.7% in 2023 owing to its compatibility with all age groups and its lesser adverse effects compared to other types of parenteral nutrition
Based on stage, the adult segment dominated the market with a revenue share of 87.1% in 2023 owing to the vulnerability of the elderly population to various chronic conditions such as cancer, diabetes, and Alzheimer's disease
Institutional sales channel dominated the market with the largest revenue share of 48.1% in 2023. On the other hand, online channels are anticipated to exhibit the fastest growth rate over the forecast period
In 2023, North America held the largest revenue share of 41.5%, while Asia Pacific is expected to witness the fastest growth due to rising healthcare expenditure, improving healthcare infrastructure, growing per capita income, and high occurrence of preterm births
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased Database
- 1.4.2. GVR's Internal Database
- 1.5. Details of primary research
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.1.1. Approach 1: Commodity flow approach
- 1.7.2. Volume price analysis (Model 2)
- 1.7.2.1. Approach 2: Volume price analysis
- 1.8. Research Scope and Assumptions
- 1.8.1. List of Secondary Sources
- 1.8.2. List of Primary Sources
- 1.8.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Nutrition Type Outlook
- 2.2.2. Stage Type Outlook
- 2.2.3. Indication Outlook
- 2.2.4. Sales Channel Outlook
- 2.3. Competitive Insights
Chapter 3. Parenteral Nutrition Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Industry Analysis
- 3.2.1. User Perspective Analysis
- 3.2.2. Key End-users
- 3.3. Technology Outlook
- 3.4. Regulatory Framework
- 3.5. Market Dynamics
- 3.5.1. Market Drivers Analysis
- 3.5.1.1. Rising geriatric population
- 3.5.1.2. Increasing natality rate
- 3.5.1.3. Increasing incidence of cancer
- 3.5.1.4. Growing number of premature births
- 3.5.1.5. Increasing risk of malnutrition
- 3.5.2. Market Restraints Analysis
- 3.5.2.1. Shortage of parenteral nutrition products
- 3.5.2.2. High risk of infections
- 3.5.3. Industry Challenges and Opportunity Analysis
- 3.6. Parenteral Nutrition Market Analysis Tools
- 3.6.1. Porter's Analysis
- 3.6.1.1. Bargaining power of the suppliers
- 3.6.1.2. Bargaining power of the buyers
- 3.6.1.3. Threats of substitution
- 3.6.1.4. Threats from new entrants
- 3.6.1.5. Competitive rivalry
- 3.6.2. PESTEL Analysis
- 3.6.2.1. Political landscape
- 3.6.2.2. Economic and Social landscape
- 3.6.2.3. Technological landscape
- 3.6.2.4. Environmental landscape
- 3.6.2.5. Legal landscape
- 3.7. Major Deals & Strategic Alliances Analysis in the Parenteral Nutrition Industry
- 3.8. Impact of COVID-19
Chapter 4. Parenteral Nutrition Market: Nutrient Type Estimates & Trend Analysis
- 4.1. Definition and Scope
- 4.2. Nutrient Type Market Share Analysis, 2023 & 2030
- 4.3. Segment Dashboard
- 4.4. Parenteral Nutrition Market: By Nutrient Type, 2018 to 2030
- 4.5. Carbohydrates
- 4.5.1. Carbohydrates Market Revenue Estimates and Forecasts, 2018 - 2030
- 4.6. Parenteral Lipid Emulsion
- 4.6.1. Parenteral Lipid Emulsion Market Revenue Estimates and Forecasts, 2018 - 2030
- 4.7. Single Dose Amino Acid Solution
- 4.7.1. Single Dose Amino Acid Solution Market Revenue Estimates and Forecasts, 2018 - 2030
- 4.8. Trace Elements
- 4.8.1. Trace Elements Market Revenue Estimates and Forecasts, 2018 - 2030
- 4.9. Vitamins & Minerals
- 4.9.1. Vitamins & Minerals Market Revenue Estimates and Forecasts, 2018 - 2030
Chapter 5. Parenteral Nutrition Market: Stage Type Estimates & Trend Analysis
- 5.1. Definition and Scope
- 5.2. Stage Type Market Share Analysis, 2023 & 2030
- 5.3. Segment Dashboard
- 5.4. Parenteral Nutrition Market: By Stage Type, 2018 to 2030
- 5.5. Adult
- 5.5.1. Adult Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6. Pediatric
- 5.6.1. Pediatric Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. Parenteral Nutrition Market: Indication Estimates & Trend Analysis
- 6.1. Definition and Scope
- 6.2. Indication Market Share Analysis, 2023 & 2030
- 6.3. Segment Dashboard
- 6.4. Parenteral Nutrition Market: By Indication, 2018 to 2030
- 6.5. Pediatrics Alzheimer's
- 6.5.1. Alzheimer's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6. Nutrition Deficiency
- 6.6.1. Nutrition Deficiency Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.7. Cancer Care
- 6.7.1. Cancer Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8. Diabetes
- 6.8.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.9. Chronic Kidney Disease
- 6.9.1. Chronic Kidney Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.10. Orphan Diseases
- 6.10.1. Orphan Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.11. Dysphagia
- 6.11.1. Dysphagia Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.12. Pain Management
- 6.12.1. Pain Management Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.13. Malabsorption/GI.Disorder/Diarrhea
- 6.13.1. Malabsorption/GI.Disorder/Diarrhea Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.14. Others
- 6.14.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. Parenteral Nutrition Market: Sales Channel Estimates & Trend Analysis
- 7.1. Definition and Scope
- 7.2. Sales Channel Market Share Analysis, 2023 & 2030
- 7.3. Segment Dashboard
- 7.4. Parenteral Nutrition Market: By Sales Channel, 2018 to 2030
- 7.5. Online
- 7.5.1. Online Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.6. Retail
- 7.6.1. Retail Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.7. Institutional
- 7.7.1. Institutional Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. Parenteral Nutrition Market: Regional Estimates & Trend Analysis by Country, Nutrient Type, Stage Type, Indication and Sales Channel
- 8.1. Definition and Scope
- 8.2. Regional Market Share Analysis, 2023 & 2030
- 8.3. Regional Market Dashboard
- 8.4. Regional Market Snapshot
- 8.5. SWOT Analysis
- 8.5.1. North America
- 8.5.2. Europe
- 8.5.3. Asia Pacific
- 8.5.4. Latin America
- 8.5.5. Middle East & Africa
- 8.6. Parenteral Nutrition Market Share, By Region, 2023 & 2030 (USD Billion)
- 8.7. North America
- 8.7.1. North America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.7.2. U.S.
- 8.7.2.1. Key Country Dynamics
- 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.7.2.3. Competitive Insights
- 8.7.2.4. U.S. Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.7.3. Canada
- 8.7.3.1. Key Country Dynamics
- 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.7.3.3. Competitive Insights
- 8.7.3.4. Canada Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8. Europe
- 8.8.1. Europe Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.2. UK
- 8.8.2.1. Key Country Dynamics
- 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.2.3. Competitive Insights
- 8.8.2.4. UK Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.3. Germany
- 8.8.3.1. Key Country Dynamics
- 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.3.3. Competitive Insights
- 8.8.3.4. Germany Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.4. France
- 8.8.4.1. Key Country Dynamics
- 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.4.3. Competitive Insights
- 8.8.4.4. France Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.5. Italy
- 8.8.5.1. Key Country Dynamics
- 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.5.3. Competitive Insights
- 8.8.5.4. Italy Parenteral Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.6. Spain
- 8.8.6.1. Key Country Dynamics
- 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.6.3. Competitive Insights
- 8.8.6.4. Spain Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.7. Sweden
- 8.8.7.1. Key Country Dynamics
- 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.7.3. Competitive Insights
- 8.8.7.4. Sweden Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.8. Denmark
- 8.8.8.1. Key Country Dynamics
- 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.8.3. Competitive Insights
- 8.8.8.4. Denmark Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.8.9. Norway
- 8.8.9.1. Key Country Dynamics
- 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
- 8.8.9.3. Competitive Insights
- 8.8.9.4. Norway Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9. Asia Pacific
- 8.9.1. Asia Pacific Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.2. China
- 8.9.2.1. Key Country Dynamics
- 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.2.3. Competitive Insights
- 8.9.2.4. China Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.3. Japan
- 8.9.3.1. Key Country Dynamics
- 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.3.3. Competitive Insights
- 8.9.3.4. Japan Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.4. India
- 8.9.4.1. Key Country Dynamics
- 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.4.3. Competitive Insights
- 8.9.4.4. India Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.5. South Korea
- 8.9.5.1. Key Country Dynamics
- 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.5.3. Competitive Insights
- 8.9.5.4. South Korea Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.6. Australia
- 8.9.6.1. Key Country Dynamics
- 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.6.3. Competitive Insights
- 8.9.6.4. Australia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.9.7. Thailand
- 8.9.7.1. Key Country Dynamics
- 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
- 8.9.7.3. Competitive Insights
- 8.9.7.4. Thailand Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10. Latin America
- 8.10.1. Latin America Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10.2. Brazil
- 8.10.2.1. Key Country Dynamics
- 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.10.2.3. Competitive Insights
- 8.10.2.4. Brazil Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10.3. Mexico
- 8.10.3.1. Key Country Dynamics
- 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.10.3.3. Competitive Insights
- 8.10.3.4. Mexico Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.10.4. Argentina
- 8.10.4.1. Key Country Dynamics
- 8.10.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.10.4.3. Competitive Insights
- 8.10.4.4. Argentina Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11. Middle East and Africa
- 8.11.1. Middle East and Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.2. Saudi Arabia
- 8.11.2.1. Key Country Dynamics
- 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.2.3. Competitive Insights
- 8.11.2.4. Saudi Arabia Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.3. UAE
- 8.11.3.1. Key Country Dynamics
- 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.3.3. Competitive Insights
- 8.11.3.4. UAE Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.4. South Africa
- 8.11.4.1. Key Country Dynamics
- 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.4.3. Competitive Insights
- 8.11.4.4. South Africa Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 8.11.5. Kuwait
- 8.11.5.1. Key Country Dynamics
- 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
- 8.11.5.3. Competitive Insights
- 8.11.5.4. Kuwait Parenteral Nutrition Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 9. Competitive Landscape
- 9.1. Recent Developments & Impact Analysis by Key Market Participants
- 9.2. Company Categorization
- 9.3. Company Market Share Analysis
- 9.4. Company Heat Map Analysis
- 9.5. Strategy Mapping
- 9.5.1. Expansion
- 9.5.2. Mergers & Acquisition
- 9.5.3. Partnerships & Collaborations
- 9.5.4. New Product Launches
- 9.5.5. Research And Development
- 9.6. Company Profiles
- 9.6.1. Baxter
- 9.6.1.1. Company Overview
- 9.6.1.2. Financial Performance
- 9.6.1.3. Product Benchmarking
- 9.6.1.4. Strategic initiatives
- 9.6.2. Allergan
- 9.6.2.1. Company Overview
- 9.6.2.2. Financial Performance
- 9.6.2.3. Product Benchmarking
- 9.6.2.4. Strategic initiatives
- 9.6.3. Actavis Inc.
- 9.6.3.1. Company Overview
- 9.6.3.2. Financial Performance
- 9.6.3.3. Product Benchmarking
- 9.6.3.4. Strategic initiatives
- 9.6.4. Otsuka Pharmaceutical Factory, Inc.
- 9.6.4.1. Company Overview
- 9.6.4.2. Financial Performance
- 9.6.4.3. Product Benchmarking
- 9.6.4.4. Strategic initiatives
- 9.6.5. Grifols, S.A.
- 9.6.5.1. Company Overview
- 9.6.5.2. Financial Performance
- 9.6.5.3. Product Benchmarking
- 9.6.5.4. Strategic initiatives
- 9.6.6. B. Braun Melsungen AG
- 9.6.6.1. Company Overview
- 9.6.6.2. Financial Performance
- 9.6.6.3. Product Benchmarking
- 9.6.6.4. Strategic initiatives
- 9.6.7. Vifor Pharma
- 9.6.7.1. Company Overview
- 9.6.7.2. Financial Performance
- 9.6.7.3. Product Benchmarking
- 9.6.7.4. Strategic initiatives
- 9.6.8. Fresenius Kabi AG
- 9.6.8.1. Company Overview
- 9.6.8.2. Financial Performance
- 9.6.8.3. Product Benchmarking
- 9.6.8.4. Strategic initiatives
- 9.6.9. Sichuan Kelun Pharmaceutical Co., Ltd
- 9.6.9.1. Company Overview
- 9.6.9.2. Financial Performance
- 9.6.9.3. Product Benchmarking
- 9.6.9.4. Strategic initiatives
- 9.6.10. Pfizer Inc. (Hospira Inc.)
- 9.6.10.1. Company Overview
- 9.6.10.2. Financial Performance
- 9.6.10.3. Product Benchmarking
- 9.6.10.4. Strategic initiatives